Company: NCEL
Filing Date: 2025-09-25
Form Type: F-1
Source: 0001213900-25-091697
Chunk: 111

Company: NewcelX Ltd.
Filing Date: 2025-09-25
Form: F-1
Chunk 111
---
 offered warrants would be issued in two series. The warrants’ exercise
prices would be USD $2.3 and USD $2.7. The warrants would be exercisable from the date of their issuance until December 31, 2023 and December
31, 2024, respectively. The full consideration was received on December 28, 2021, and the Company issued shares and warrants in accordance
with the Placement Agreement. As of December 31, warrants totaling 70,356 had expired.

| I. | On December 12, 2022, the shareholders’ meeting approved the increase of the Company’s authorized                                 
 share capital by 50,000,000 shares, no par value, and the capital increase, respectively, so that after the capital increase, the 
 authorized share capital of the Company was USD $2.9 million, divided into 100,000,000 ordinary shares.                           |

On December 12, 2022, the Company published
a shelf offering by way of rights. Under the shelf offering, shares were offered by way of rights to the Company’s shareholders,
in such a way that each shareholder who held 100 Shares would be entitled to purchase 1 rights unit. 1 rights unit consisted of 32 Shares,
and the total price of each rights unit was USD $10. The total number of rights units offered was up to 14,623,392 rights units.

Until December 31, 2022, the Company
received notices for 47,574 rights (in exchange for which 1,522,335 shares were issued as of the reporting date) for a total of USD
$475 thousand.

By the end of the financing round on
January 9, 2023, the Company received notices for 390,220 rights to purchase 7,507,052 Shares of the Company. The gross immediate consideration
received by the Company for the rights issued according to the shelf offering totaled USD $2,204 thousand (the issuance expenses totaled
USD $52 thousand).

On January 1, 2023, 2,175,800 Series
6 warrants expired.

| J. | During the year 2023, the shareholders’ meeting approved the increase of the Company’s authorized                                     
 share capital by 50,000,000 Shares, and the capital increase, respectively, so that the authorized share capital of the Company after 
 the capital increase would be USD $4.4 million, divided into 150,000,